As a result, CD64/FcγRI, CD80, CD86, and CXCR2 were selected as candidate molecules based on statistically significant downregulation or upregulation in RA patient or control monocyte cultures with abatacept compared with the mock cultures (P < 0.1). The gene discussed is CD86; the disease is rheumatoid arthritis.